457 related articles for article (PubMed ID: 27013635)
1. miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach.
Shi L; Kojonazarov B; Elgheznawy A; Popp R; Dahal BK; Böhm M; Pullamsetti SS; Ghofrani HA; Gödecke A; Jungmann A; Katus HA; Müller OJ; Schermuly RT; Fisslthaler B; Seeger W; Fleming I
Cardiovasc Res; 2016 Aug; 111(3):184-93. PubMed ID: 27013635
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
[TBL] [Abstract][Full Text] [Related]
3. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
[TBL] [Abstract][Full Text] [Related]
4. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
[TBL] [Abstract][Full Text] [Related]
5. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in right ventricular remodelling.
Batkai S; Bär C; Thum T
Cardiovasc Res; 2017 Oct; 113(12):1433-1440. PubMed ID: 28957533
[TBL] [Abstract][Full Text] [Related]
7. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
[TBL] [Abstract][Full Text] [Related]
8. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
[TBL] [Abstract][Full Text] [Related]
9. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis.
Bruce E; Shenoy V; Rathinasabapathy A; Espejo A; Horowitz A; Oswalt A; Francis J; Nair A; Unger T; Raizada MK; Steckelings UM; Sumners C; Katovich MJ
Br J Pharmacol; 2015 May; 172(9):2219-31. PubMed ID: 25522140
[TBL] [Abstract][Full Text] [Related]
10. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
[TBL] [Abstract][Full Text] [Related]
12. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia.
Bohuslavová R; Kolář F; Kuthanová L; Neckář J; Tichopád A; Pavlinkova G
J Appl Physiol (1985); 2010 Oct; 109(4):1195-202. PubMed ID: 20634361
[TBL] [Abstract][Full Text] [Related]
14. Analyses of long non-coding RNA and mRNA profiles in right ventricle myocardium of acute right heart failure in pulmonary arterial hypertension rats.
Cao Y; Yang Y; Wang L; Li L; Zhang J; Gao X; Dai S; Zhang Y; Guo Q; Peng YG; Wang E
Biomed Pharmacother; 2018 Oct; 106():1108-1115. PubMed ID: 30119177
[TBL] [Abstract][Full Text] [Related]
15. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
Antigny F; Mercier O; Humbert M; Sabourin J
Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
[TBL] [Abstract][Full Text] [Related]
16. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
Veith C; Neghabian D; Luitel H; Wilhelm J; Egemnazarov B; Muntanjohl C; Fischer JH; Dahal BK; Schermuly RT; Ghofrani HA; Grimminger F; Fink L; Kwapiszewska G; Weissmann N; Sydykov A
Basic Res Cardiol; 2020 Jan; 115(2):17. PubMed ID: 31980934
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-140 is elevated and mitofusin-1 is downregulated in the right ventricle of the Sugen5416/hypoxia/normoxia model of pulmonary arterial hypertension.
Joshi SR; Dhagia V; Gairhe S; Edwards JG; McMurtry IF; Gupte SA
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H689-98. PubMed ID: 27422986
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation.
Yang Q; Sun M; Ramchandran R; Raj JU
Vascul Pharmacol; 2015 Oct; 73():20-31. PubMed ID: 25921925
[TBL] [Abstract][Full Text] [Related]
19. Alterations in cardiovascular function in an experimental model of lung fibrosis and pulmonary hypertension.
Darwiche T; Collum SD; Bi W; Reynolds JO; Wilson C; Wareing N; Hernandez AM; Mertens TCJ; Zhou Z; Pandit LM; Karmouty-Quintana H
Exp Physiol; 2019 Apr; 104(4):568-579. PubMed ID: 30663834
[TBL] [Abstract][Full Text] [Related]
20. Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing.
Esfandiary A; Kutsche HS; Schreckenberg R; Weber M; Pak O; Kojonazarov B; Sydykov A; Hirschhäuser C; Wolf A; Haag D; Hecker M; Fink L; Seeger W; Ghofrani HA; Schermuly RT; Weißmann N; Schulz R; Rohrbach S; Li L; Sommer N; Schlüter KD
Cardiovasc Res; 2019 Jun; 115(7):1217-1227. PubMed ID: 30850841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]